Stone House Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-90
| Closed | -$3.06K | – | 532 |
|
|
2025
Q1 | $3.06K | Buy |
+90
| New | +$3.06K | ﹤0.01% | 359 |
|
|
2024
Q4 | – | Sell |
-460
| Closed | -$21.6K | – | 120 |
|
|
2024
Q3 | $21.6K | Sell |
460
-66
| -13% | -$3.1K | ﹤0.01% | 174 |
|
|
2024
Q2 | $28.4K | Sell |
526
-43
| -8% | -$2.32K | 0.01% | 161 |
|
|
2024
Q1 | $38.8K | Buy |
569
+400
| +237% | +$27.3K | 0.01% | 145 |
|
|
2023
Q4 | $10.6K | Sell |
169
-27
| -14% | -$1.69K | ﹤0.01% | 160 |
|
|
2023
Q3 | $8.9K | Hold |
196
| – | – | ﹤0.01% | 169 |
|
|
2023
Q2 | $11K | Hold |
196
| – | – | ﹤0.01% | 155 |
|
|
2023
Q1 | $8.87K | Buy |
+196
| New | +$8.87K | ﹤0.01% | 171 |
|